(Q46540346)

English

Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

author name string

J E Castro

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

C E Prada

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

R A Aguillon

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

S Kitada

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

T Fukuda

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

M Motta

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

C Wu

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

F Dicker

8

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

G Sun

9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

J Y J Wang

10

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

D A Carson

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

J C Reed

12

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

T J Kipps

13

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

publication date

1 April 2006

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

20

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

680-688

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404144

0 references

Gene inhibition using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Site specific enzymatic cleavage of RNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Progress in antisense technology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Dysregulation of apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

A two-phase model of B-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Cytometric bead array: a multiplexed assay platform with applications in various areas of biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Antisense RNA down-regulation of bcl-2 expression in DU145 prostate cancer cells does not diminish the cytostatic effects of G3139 (Oblimersen).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Apoptosis-targeted therapies for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Improving cancer therapy by non-genotoxic activation of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Genotoxic and non-genotoxic pathways of p53 induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Regulation of cell death by the Abl tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Inhibition of Bid-induced apoptosis by Bcl-2. tBid insertion, Bax translocation, and Bax/Bak oligomerization suppressed

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

BID: a novel BH3 domain-only death agonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

21 January 2018

Promise and problems of Bcl-2 antisense therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein kinase C activity and phosphoprotein pattern in stimulated alveolar macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

7 January 2021

based on heuristic

inferred from DOI database lookup

From A to Z on CpG

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA damage and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404144

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404144

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

release_yqu4exioszcbdcenvnb7c5h5oy

1 reference

https://api.fatcat.wiki/v0/release/yqu4exioszcbdcenvnb7c5h5oy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16498393

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46540346&oldid=2116965203"